CA2070813A1 - Une methode permettant de determiner la concentration d'anticoagulants - Google Patents

Une methode permettant de determiner la concentration d'anticoagulants

Info

Publication number
CA2070813A1
CA2070813A1 CA2070813A CA2070813A CA2070813A1 CA 2070813 A1 CA2070813 A1 CA 2070813A1 CA 2070813 A CA2070813 A CA 2070813A CA 2070813 A CA2070813 A CA 2070813A CA 2070813 A1 CA2070813 A1 CA 2070813A1
Authority
CA
Canada
Prior art keywords
anticoagulatory
thrombin
concentration
active components
anticoagulants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2070813A
Other languages
English (en)
Other versions
CA2070813C (fr
Inventor
Hendrik Coenraad Hemker
Robert Johan Wagenvoord
Hans-Jurgen Kolde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2070813A1 publication Critical patent/CA2070813A1/fr
Application granted granted Critical
Publication of CA2070813C publication Critical patent/CA2070813C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/815Protease inhibitors from leeches, e.g. hirudin, eglin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974Thrombin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, e.g. Konjac gum, Locust bean gum, Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)
CA002070813A 1990-11-05 1991-10-30 Une methode permettant de determiner la concentration d'anticoagulants Expired - Fee Related CA2070813C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60934090A 1990-11-05 1990-11-05
US609,340 1990-11-05

Publications (2)

Publication Number Publication Date
CA2070813A1 true CA2070813A1 (fr) 1992-05-06
CA2070813C CA2070813C (fr) 1996-10-29

Family

ID=24440379

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002070813A Expired - Fee Related CA2070813C (fr) 1990-11-05 1991-10-30 Une methode permettant de determiner la concentration d'anticoagulants

Country Status (10)

Country Link
US (1) US5702912A (fr)
EP (1) EP0509086B1 (fr)
JP (1) JP3094165B2 (fr)
AT (1) ATE121139T1 (fr)
AU (1) AU650941B2 (fr)
CA (1) CA2070813C (fr)
DE (1) DE69108896T2 (fr)
DK (1) DK0509086T3 (fr)
ES (1) ES2073908T3 (fr)
WO (1) WO1992007954A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4203980A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Verfahren zur bestimmung von hirudin und synthetischen thrombininhibitoren
AT397391B (de) * 1992-05-15 1994-03-25 Immuno Ag Verwendung von prothrombinfragmenten
US5308755A (en) * 1992-06-08 1994-05-03 Research Corporation Technologies, Inc. Method for measuring heparin
RU2153506C2 (ru) * 1993-09-30 2000-07-27 Сейкагаку когио кабусики кайся Дерматансульфат или его соль, противотромбозные средства, способ предупреждения или лечения тромбозов, способ предупреждения или лечения синдрома рассеянной интраваскулярной коагуляции, способ лечения инфаркта миокарда
AU711702B2 (en) * 1995-03-23 1999-10-21 Cambridge University Technical Services Limited Vectors for gene delivery
US6010911A (en) * 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US5985582A (en) * 1997-12-09 1999-11-16 Sigma-Aldrich Co. Thrombin-based assay for antithrombin III
WO1999038997A1 (fr) * 1998-01-30 1999-08-05 Yoshitomi Pharmaceutical Industries, Ltd. Procede de mesure de l'activite du cofacteur ii de l'heparine et boite de reactifs y relative
US6194394B1 (en) * 1998-07-01 2001-02-27 Sigma-Aldrich Co. Coagulation controls for prothrombin time (PT) and activated partial thromboplastin time (APTT) assays
DE19904674A1 (de) * 1999-02-04 2000-08-31 Haemosys Gmbh Verfahren zur Bestimmung der Konzentration von Thrombininhibitoren
EP1045250A1 (fr) * 1999-04-12 2000-10-18 INSTRUMENTATION LABORATORY S.p.A. Test pour l'évaluation de la fonctionnalité du système thrombine/antithrombine
AUPP971299A0 (en) 1999-04-12 1999-05-06 South Eastern Sydney Area Health Service Procoagulant assay
JP2003524187A (ja) * 2000-02-23 2003-08-12 ベッスト−テスト アンパーツゼルスカブ 体液、例えば尿におけるマーカーと血液凝固活性とを相互関連づけるための方法
US6680177B2 (en) * 2001-12-07 2004-01-20 Cardiovascular Diagnostics, Inc. Low molecular weight heparin assay, system and reagent therefor
DE10330900B4 (de) * 2003-07-01 2006-09-14 Leibniz-Institut Für Polymerforschung Dresden E.V. Biomaterial mit einem modularen Beschichtungssystem zur Anwendung in Medizinprodukten mit direktem Blutkontakt
CA2566411A1 (fr) * 2004-05-11 2005-11-24 Heptest Laboratories, Inc. Compositions, kit et procede en une etape permettant de surveiller des composes possedant des activites d'antifacteur xa et/ou d'antifacteur iia
CA2567137A1 (fr) 2004-05-17 2005-12-08 Medtronic, Inc. Systeme de determination de l'heparine au point de service
BRPI0511603A (pt) * 2004-05-27 2008-01-02 Avigen Inc método para o tratamento de distúrbios do sangramento com a utilização de polissacarìdeos sulfatados
DE102005038418A1 (de) * 2005-08-12 2007-02-15 Dade Behring Marburg Gmbh Faktor Xa-basierter Heparinassay unter Verwendung einer Heparin-modifizierenden Komponente
DE102006035580A1 (de) * 2006-07-27 2008-02-14 Csl Behring Gmbh Bestimmung der biologischen Aktivität von Heparin in AT III-haltigen Präparationen
EP1918718A1 (fr) 2006-10-31 2008-05-07 Roche Diagnostics GmbH Procédés et dispositifs destinés à la détermination électrochimique d'inhibiteurs du facteur Xa dans des échantillons sanguins
US20120178114A1 (en) * 2007-08-10 2012-07-12 Subc, Inc. Methods and devices for detecting thrombin generation
EP2471945A1 (fr) * 2010-12-30 2012-07-04 Siemens Healthcare Diagnostics Products GmbH Procédé de détermination d'inhibiteurs de coagulation
JP6087775B2 (ja) * 2013-09-13 2017-03-01 薫 梅野 ハンドバイブレーターおよびハンドバイブレーター用連結具
WO2018128002A1 (fr) * 2017-01-06 2018-07-12 ソニー株式会社 Analyseur de système de coagulation sanguine, système d'analyse de système de coagulation sanguine, procédé d'analyse de système de coagulation sanguine, programme d'analyse de système de coagulation sanguine, prédicteur de volume hémorragique, système de prédiction de volume hémorragique, procédé de prédiction de volume hémorragique et programme de prédiction de volume hémorragique
CN110514851A (zh) * 2019-08-28 2019-11-29 深圳麦科田生物医疗技术有限公司 血小板抑制率的检测方法和检测试剂盒

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2812943C3 (de) * 1978-03-23 1981-05-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma
DE3005540A1 (de) * 1980-02-14 1981-08-20 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagens zur bestimmung der biologischen aktivitaet von heparin im plasma
WO1982001377A1 (fr) * 1980-10-09 1982-04-29 Lill Helmut Procede de determination d'une bm ('binding moderately') antithrombine
US4473639A (en) * 1982-09-15 1984-09-25 Miles Laboratories, Inc. Reagent strip test for antithrombin-III
US4851336A (en) * 1985-09-05 1989-07-25 Yin E Thye Composition, kit, and method for assaying heparinano a method for making the composition
DE3536903A1 (de) * 1985-10-16 1987-04-16 Boehringer Mannheim Gmbh Verfahren zur photometrischen bestimmung von protein c
IT1230744B (it) * 1989-07-07 1991-10-29 Instrumentation Lab Spa Metodo per la determinazione della attivita' funzionale della proteina s nel plasma umano.
NL8902406A (nl) * 1989-09-27 1991-04-16 Hendrik Coenraad Hemker Prof D Werkwijze voor het bepalen van de endogene trombinepotentiaal van plasma, en bloed alsmede een bij deze werkwijze te gebruiken kit.

Also Published As

Publication number Publication date
AU650941B2 (en) 1994-07-07
JP3094165B2 (ja) 2000-10-03
DE69108896D1 (de) 1995-05-18
EP0509086B1 (fr) 1995-04-12
EP0509086A1 (fr) 1992-10-21
JPH05503223A (ja) 1993-06-03
WO1992007954A1 (fr) 1992-05-14
DK0509086T3 (da) 1995-07-03
AU1015492A (en) 1992-06-25
ATE121139T1 (de) 1995-04-15
DE69108896T2 (de) 1995-08-24
CA2070813C (fr) 1996-10-29
US5702912A (en) 1997-12-30
ES2073908T3 (es) 1995-08-16

Similar Documents

Publication Publication Date Title
CA2070813A1 (fr) Une methode permettant de determiner la concentration d'anticoagulants
US20090087870A1 (en) Hematological assay and kit
EP0632270A4 (fr) Procede de determination de l'activite du facteur de coagulation sanguine xiii et trousse de reactifs appropries.
AU694931B2 (en) A method for detecting disturbances of the protein C/protein S system
US4918001A (en) Method for the determination of protease inhibitors
DE69216583T2 (de) Bestimmungsverfahren fur protein s
US5320945A (en) Method and reagent for the determination of antithrombin III
ATE136367T1 (de) Verfahren zur bestimmung von hirudin und synthetischen trhombininhibitoren
US6100050A (en) Factor VIII:Ca chromogenic assay
EP0491895B1 (fr) DOSAGE CHROMOGENIQUE SERVANT A DETERMINER LE FACTEUR VIII:Ca
US5753510A (en) Calibrator for use in test methods for detecting a defective coagulation factor V
SK48693A3 (en) Method of determination of fibrinogen
JPH04350560A (ja) プロテインs活性の機能的測定方法
US7923217B2 (en) Specificity in the determination of antithrombin
Becker et al. Development of a photometric assay for activated partial thromboplastin time and its application to the cobas (R) biocentrifugal analyzer
Cumming et al. The assay of factor VIII: C in heparinized plasma: a polybrene neutralization method
MX9709961A (es) Prueba de riesgo de trombosis.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed